title: Reproductive system in familial Mediterranean fever: an overview.
abstract: Familial Mediterranean fever (FMF), amyloidosis, and colchicine may affect the reproductive system of male and female patients. Colchicine treatment improves female fertility and the outcome of pregnancy and may prevent the development of amyloidosis. However, colchicine may induce oligospermia/azoospermia, but this effect is rare. Overall, colchicine treatment improves the prognosis of patients with FMF and increases their reproductive ability.
authors.affiliation: FMF Unit, Department of Medicine, Hadassah University Hospital, Jerusalem, Israel. eldad@Hadassah.org.il
authors.forename: E
authors.initials: E
authors.lastname: Ben-Chetrit
authors.forename: M
authors.initials: M
authors.lastname: Levy
mesh_terms: D000014:Abnormalities, Drug-Induced; D000022:Abortion, Spontaneous / Q000139:chemically induced; D000686:Amyloidosis / Q000188:drug therapy / Q000209:etiology; D001942:Breast Feeding; D003078:Colchicine / Q000009:adverse effects / Q000627:therapeutic use*; D010505:Familial Mediterranean Fever / Q000188:drug therapy*; D005260:Female; D005298:Fertility; D006801:Humans; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008598:Menstruation; D009845:Oligospermia / Q000139:chemically induced; D010049:Ovarian Diseases / Q000188:drug therapy / Q000209:etiology; D011247:Pregnancy; D013733:Testicular Diseases / Q000188:drug therapy / Q000209:etiology
chemical_list: D003078:Colchicine